Cargando…
Treatment strategies for clozapine-induced hypotension: a systematic review
BACKGROUND: Clozapine is the most effective medication for treatment–refractory schizophrenia but is associated with significant adverse drug effects, including hypotension and dizziness, which have a negative impact on quality of life and treatment compliance. Available evidence for the management...
Autores principales: | Tanzer, Timothy David, Brouard, Thomas, Pra, Samuel Dal, Warren, Nicola, Barras, Michael, Kisely, Steve, Brooks, Emily, Siskind, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136453/ https://www.ncbi.nlm.nih.gov/pubmed/35633931 http://dx.doi.org/10.1177/20451253221092931 |
Ejemplares similares
-
Metformin for Clozapine Associated Obesity: A Systematic Review and Meta-Analysis
por: Siskind, Dan J., et al.
Publicado: (2016) -
T44. 12-MONTH FOLLOW UP OF METABOLIC MEASURES FOLLOWING A RANDOMISED CONTROLLED TRIAL OF TREATMENT OF CLOZAPINE ASSOCIATED OBESITY AND DIABETES WITH EXENATIDE (CODEX)
por: Siskind, Dan, et al.
Publicado: (2020) -
41.1 WHAT DO META-ANALYSES TELL US ABOUT CLOZAPINE’S EFFICACY AND EFFECTIVENESS FOR TREATMENT REFRACTORY SCHIZOPHRENIA?
por: Siskind, Dan, et al.
Publicado: (2018) -
T160. TREATMENT OF CLOZAPINE-ASSOCIATED OBESITY AND DIABETES WITH EXENATIDE (CODEX) IN ADULTS WITH SCHIZOPHRENIA: A RANDOMISED CONTROLLED TRIAL
por: Siskind, Dan, et al.
Publicado: (2018) -
Effects of semaglutide on body weight in clozapine-treated people with schizophrenia and obesity: study protocol for a placebo-controlled, randomised multicentre trial (COaST)
por: Siskind, Dan, et al.
Publicado: (2023)